drugset
drugset / Trial / NCT05595083

Intranasal vs. IV Dexmedetomidine in Endoscopic Sinus Surgery

NCT05595083 ↗

Unknown 54 enrolled Kafrelsheikh University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to compare intranasal dexmedetomidine versus intravenous dexmedetomidine for improving the quality of the operative field in Functional endoscopic sinus surgery (FESS).

Timeline

Start
2022-11-01
Primary completion
2023-10-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg Intranasal
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Intranasal
Subject Dexmedetomidine Other / unclassified 1.5 ug/kg Intranasal

Indications

No indication recorded.